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Departments of Medicine and Pathology, PeterBent Brigham Hospital and Harvard Medical School, Boston,
Massachusetts
Acute renal failure induced by diethylaminoethyl dextran: Im-
portance of cationic charge. The administration of polydispersed,
polycationic, diethylaminoethyl (DEAE) dextran in high dosages
(500 mg) induces acute renal failure both morphologically and
functionally in Sprague-Dawley rats. Forty-eight hours after in-
jection of high dose DEAE, rats had BUN elevations exceeding
50 mg/dl and evidence of severe epithelial cell necrosis in S1 and
52 segments of the proximal tubule. These functional and mor-
phologic alterations in the kidney were not seen in animals given
equivalent doses of neutral dextran. Because recent evidence
has implicated renal mitochondrial injury as an important patho-
genetic pathway in nephrotoxic acute renal failure, the effect of
DEAE on renal mitochondrial respiration was determined after
in vivo and in vitro exposure. Isolated renal cortical mito-
chondria were obtained from 6 rats 24 hours after a low dose of
DEAE (40 mg/kg). Compared with mitochondrial respiratory rates
of 6 sham control rats, state 3 (ADP-dependent) respiration fell
from 622 (5EM) 11 to 470 18 (P < 0.001), state 4 respiration
declined from 166 6 to 144 3 (P < 0.01), and DNP-uncoupled
respiration fell from 506 8 to 427 17 (P < 0.001) nanoatom
equivalents of oxygen per milligram of protein per minute. These
alterations occurred without BUN elevation or ultrastructural
evidence of renal cell injury. An identical dose of neutral dextran
had no effect on mitochondrial respiratory parameters compared
with controls. Alterations in renal mitochondrial respiration
were also found after in vitro incubation of isolated mitochondria
with DEAE but not with neutral dextran. These results, there-
fore, implicate cationic charge as a molecular determinant of
DEAE-related mitochondrial and renal toxicities, in particular,
and suggest that cationic charge and renal mitochondrial injury
are important molecular and pathogenetic determinants of neph-
rotoxic acute renal failure, in general.
Insuffisance rénale aigué induite par le dextran diéthylamino-
ethyl: Importance de Ia charge cationique. L'administration a
hautes doses (500 mg) de diéthylaminoéthyl dextran (DEAE)
polydispersé et polycationique determine une insuffisance rénale
aigue a Ia fois morphologique et fonctionnelle chez le rat
Sprague-Dawley. Quarante huit heures après l'injection de
hautes doses de DEAE les rats avaient des augmentations de
l'azote uréique sanguin supérieures a 50 mg/dl et des signes de
nécroses cetlulaires sévères des segments S1 et S2 du tube proxi-
mal. Ces modifications fonctionnelles et morphologiques n'ont
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pas été observées chez les animaux qui ont recu du dextran
neutre. Du fait que des arguments récents ont impliqué des lé-
sions des mitochondries rénales dans la pathogénie de
l'insuffisance rénale aiguë néphrotoxique les effets de DEAE sur
Ia respiration mitochondriale ont été déterminés après une expo-
sition in vitro et in vivo. Des mitochondries isolées ont été ob-
tenues a partir de 6 rats 24 heures après une faible dose de
DEAE (40 mg/kg). Par comparaison avec les debits respiratoires
des mitochondries de 6 rats contrôles on observe une diminution
de Ia respiration du stade 3 (dépendant de l'ADP) de 622 (sEM)
11à470± 18(P<0,00l),dustade4del66±6à144±3(P<
0,01), et la respiration découplée par le DNP passe de 506 8 a
427 17 (P < 0,001) nanoatomes equivalents d'oxygène par mil-
ligram de protéines par minute. Ces modifications surviennent
sans augmentation de l'azote uréique du plasma et sans signes de
lesions cellulaires rénales. Une méme dose de dextran neutre n'a
pas d'effet sur la respiration mitochondriale. Des modifications
de la respiration des mitochondries rénales ont aussi été obser-
vées après l'incubation in vitro de mitochondries isolées avec
DEAE mais pas avec le dextran neutre. Ces résultats, par con-
sequent, impliquent les charges cationiques comme un deter-
minant molCculaire des toxicités rénale et mitochondriale du
DEAE. Ils suggèrent que les charges cationiques et le lesions des
mitochondries rénales sont des determinants de l'insuffisance ré-
nale aigué nephrotoxique.
Although the list of nephrotoxic agents is long
and varied, it is predominated by substances that
are cationic at a physiologic pH, including organic
polycations (aminoglycoside antibiotics) and in-
organic cations (heavy metals). Furthermore, the
cationic nature of the endogenous proteins, myo-
globin and myeloma light chains, appears to be an
important determinant of their nephrotoxic poten-
tial [1, 2].
Recent evidence suggests that gentamicin-in-
duced renal mitochondrial injury is an important
pathogenetic event in gentamicin nephrotoxicity
[3]. In fact, a striking direct correlation between the
cationic charge of aminoglycosides, mitochondrial
toxicity, and nephrotoxicity has been demonstrated
[4]. To further test the importance of cationic
charge as a molecular determinant of renal mito-
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chondrial injury as well as overall renal toxicity, we
examined the mitochondrial and renal effects of
polydispersed, polycationic diethylaminoethyl(DEAE) dextran and compared these effects with
the effects of neutral dextran. DEAE dextran was
chosen for study because it possesses a molecular
structure similar to that of aminoglycoside antibiot-
ics. The aminoglycosides consist of various sugar
molecules in glycosidic linkage with amino-contain-
ing side chains. These amino groups impart the cat-
ionic nature to these molecules. Likewise, DEAE
dextran consists of linearly branched chains of glu-
cose residues connected by glycosidic linkages with
diethylaminoethyl side chains. The results of these
studies demonstrate that DEAE dextran has consid-
erable mitochondrial and renal toxicity, and these
toxicities are not observed with neutral dextran.
Methods
Mitochondrial isolation. Isolated renal cortical
mitochondria samples were prepared by a modifica-
tion of the method of Johnson and Lardy [5].
Sprague-Dawley rats, each weighing 250 to 300 g,
were stunned, then decapitated. The kidneys were
rapidly removed and placed in 0.25 M sucrose (pH,
7.4; 4° C) so that a weight-to-volume ratio of ap-
proximately 1 to 30 was achieved. After the capsule
and fat were removed, the kidneys were longitudi-
nally divided, and the cortex was separated from
the remainder of the kidney. The renal cortex was
then homogenized with seven smooth up and down
strokes of a Dounce homogenizer. The homogenate
was immediately centrifuged at x600g at 40 C in a
refrigerated centrifuge (Sorval model RC-2). The re-
sulting supernatant was centrifuged at x 15 ,000g at
40 C for 5 mm to sediment the mitochondria. The
pellet was resuspended in 0.25 M sucrose and re-
centrifuged once more at x 15,000g at 40 C for 5
mm. The final pellet was resuspended in 0.25 M su-
crose to give a protein concentration of approxi-
mately 10 mg of protein per milliliter. Protein con-
centrations were determined by the method of Low-
ry et al [6].
Mitochondrial oxygen consumption. Oxygen
consumption of isolated mitochondria was mea-
sured polarographically [7], at 250 C by a Clark
electrode in a calibrated 2-ml vessel with stirring
bar and thermostatically controlled bath (Model K-
IC, Gilson Medical Electronics, Inc., Middleton,
Wisconsin). The incubation medium contained 260
m sucrose, 10 ifiM Tris monobasic potassium
phosphate, 5 mi'vi Tris hydrochloric acid (pH, 7.4),
0.2 mrvt EDTA, and 10 m sodium succinate. Each
experiment was started by adding mitochondria to
achieve a concentration of 1 to 2 mg of protein per
milliliter in the oxygraph cell. The following respira-
tory parameters were then measured to assess vari-
ous aspects of mitochondrial function: (1) state 3
respiration, ADP-dependent mitochondrial oxygen
consumption determined after the addition of 200
nmoles of sodium ADP; (2) state 4 respiration, the
slower ADP independent oxygen consumption de-
termined after depletion of the added ADP that in-
duced state 3 respiration; (3) ADP:O (P:O) ratio,
moles of ADP converted to ATP by 1 gram atom of
oxygen, theoretically equal to 2.0 with succinate as
substrate; (4) acceptor control ratio (ACR), defined
as state 3 respiratory rate/state 4 respiratory rate;
(5) 2-4-dinitrophencI (DNP) -stimulated respiration,
uncoupled oxygen consumption determined after
the addition of DNP as a l0-4 absolute ethanol so-
lution to produce a final concentration of 50 /LM.
Oxygen consumption calculations were based on
an oxygen solubility in the buffer exposed to room
air at 25° C of 474 natom equivalents per milliliter
[8]. All respiratory rates are, therefore, given in
units of nanoatom equivalents of oxygen per milli-
gram of mitochondrial protein per minute.
In vivo experiments: (1) High-dose DEAE. All ex-
periments in this study were performed on male
Sprague-Dawley rats (body wt, 250 to 300 g) having
free access to water and a standard rat chow diet.
For the renal morphologic and functional studies,
three groups of 8 rats each were used. The first
group received, s.c., 500mg of DEAE dextran (high
dose) dissolved in 2 ml of water; the second group
received, s.c., 500 mg of neutral dextran; the third
group received a sham injection of 2 ml of water.
Tail vein blood from each rat was collected at 24,
48, and 72 hours after injection and assayed for
blood urea nitrogen (BUN) with a BUN analyzer
(Beckman model 6519, Fullerton, California). The
kidneys of two animals from each group were per-
fused-fixed in vivo at 24, 36, 48, and 72 hours after
injection and examined for morphology.
(2) Low-dose DEAE. Because of the severe renal
injury seen with high-dose DEAE, a lower dose of
DEAE was used to assess renal mitochondrial func-
tion at a time when kidney function and morphology
was not disturbed. For the in vivo mitochondrial ex-
periments, an additional three groups, of 6 rats
each, were used. The first group received 40 mg/kg
DEAE dextran (low dose) i.p.; the second group re-
ceived 40 mg/kg neutral dextran i.p.; the third group
received a sham infusion of 2 ml of water. Six ani-
mals from each group had tail vein blood collected
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for BUN determination at 24 hours following injec-
tion and were immediately sacrificed for renal mito-
chondrial isolation. Furthermore, 5 additional rats
had their kidneys perfused-fixed in vivo at 24 hours
after low-dose DEAE injection.
In vitro experiments. In addition to the in vivo
experiments, studies were done to examine the di-
rect effects of DEAE dextran on isolated renal mito-
chondria. Six other rats were sacrificed, mito-
chondria were isolated from renal cortex, and mito-
chondrial respiration was studied. Mitochondrial
preparations were discarded if control ACR was
less than 3.0, when tested with succinate as sub-
strate. Each experiment was started by adding
mitochondria to the oxygraph cell containing in-
cubation medium and substrate. At 1 mm, either
DEAE, neutral dextran, or sham control (50 p1 of
distilled water) was added to the incubation medium
as a 50-p1 solution to attain a final dextran concen-
tration of 100 gIml. After approximately 2 to 3 mm
of baseline respiration, ADP or DNP were added to
determine state 3 or DNP-uncoupled respiratory
rates.
Morphologic studies. To assess the morphologic
effects of high- and low-dose DEAE dextran, we
perfused-fixed, in vivo, kidneys from treated ani-
mals. In vivo perfusion of the aorto-renal axis was
performed in anesthetized rats at 110 mm Hg with
glutaraldehyde fixative at a concentration of 1.25%
in 0.1 M sodium cacodylate buffer (pH, 7.4) for 5
mm through an aortic PE-l60 polyethylene catheter
immediately following cross-clamping above the
renal arteries. Multiple renal cortical slices were
postfixed in osmium tetroxide for 90 mm, dehy-
drated in alcohol, and embedded in Epon 812. Thick
sections (1 to 2 p1 were stained with 1% aqueous
toluidine blue in 1% borax for light microscopy.
Thin sections (500 to 1000 A) were cut with dia-
mond knives and stained on copper grids with ura-
nyl acetate and lead citrate. Examination of pre-
pared sections was performed on a transmission
electron microscope (Philips 201, Philips Electronic
Instruments, Eindhoven, The Netherlands). By
both light and electron microscopy, S, S4, and S3
cells in proximal tubules were identified in tissue
sections by their histotopographic distribution and
by morphologic criteria [9].
Reagents. DEAE dextran was obtained from
Pharmacia Fine Chemicals, Inc. (Piscataway, New
Jersey). In the commercially available form, DEAE
has an average mol wt of 500,000 daltons. This com-
mercial preparation was hydrolyzed to obtain a
polydispersed lower molecular weight fraction. Hy-
drolysis was carried out by adding 1 g of DEAE to
18 ml of water and 2 ml of I N hydrochloric acid and
heating to 100° C for 40 mm. The resulting solution
was then lyophilized to a powder form.
Neutral dextran was prepared with equivalent
quantities of dextran T10, T20, and T40, obtained
from Pharmacia.
All other chemicals were obtained from Sigma
Chemical Co. (St. Louis, Missouri).
Statistical methods. Student's paired and un-
paired t tests were used when appropriate for statis-
tical analysis. Significance is defined as P < 0.05,
two tailed.
Results
High dose DEAE. Rats receiving DEAE, 500 mg,
showed a marked rise in BUN from a control level
of 15 2 to 25 4 mgldl at 24 hours, 62 7 mgldl at
48 hours, and greater than 100 mgldl at 72 hours fol-
lowing injection. No rise in BUN was observed in
the neutral dextran or sham-treated animals. At 24
hours after injection, S and S2 segments showed
signs of early and focal cell damage with increased
cell vacuolization and individual cell necrosis (Fig.
lb). At 48 hours, severe acute tubular necrosis was
evident morphologically (Fig. 1, c and d). At this
time, most S and S2 cells were completely necrotic;
desquamation of necrotic epithelial cells in S and S2
segments was common and resulted in the appear-
ance of large patches of denuded tubular basement
membrane. Occasional S3 segments were impacted
with cytoplasmic blebs and cellular debris, but S3
cells, unlike S and S2 cells, exhibited a normal ap-
pearance ultrastructurally (Fig. ic). These morpho-
logic alterations were seen as early as 36 hours after
DEAE administration. The morphologic evidence
of DEAE toxicity was limited to the kidney, be-
cause no signs of toxic or ischemic ultrastructural
damage were seen in other examined organs, in-
cluding liver and spleen, in any animal 48 hours af-
ter DEAE administration.
Mitochondrial function after in vivo low-dose
DEAE exposure. Figure 2 summarizes the mean
values for state 4, state 3, and DNP-uncoupled res-
piration by renal cortical mitochondria from rats
treated with DEAE and neutral dextran and sham-
treated rats. State 4 respiration in DEAE-treated
rats averaged 144 3, significantly lower (P <0.01)
than the control animals' mean value of 166 6
natom equivalents of oxygen per milligram of pro-
tein per minute (natom Eq O2/mglmin). Neutral dex-
tran had no effect on state 4 respiration compared
with controls, averaging 172 6 and 166 6 natom
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Fig. 1. Proximal tubule profiles including S, and S2 seg,nents of sham control and DEAE-treated ani,nals. a Light micrograph shows
control kidney (x425). b Light micrograph shows kidney 24 hours after high-dose DEAE administration. S1 and S2 segments (indicated
by asterisks) show individual cell necrosis with increased cell vacuolization (X425). c Light micrograph shows kidney 48 hours after high-
dose DEAE administration with extensive desquamation of necrotic epithelial cells in S1 and S2 segments (asterisks). S3 segments to the
left of the figure appear without significant cell injury (x 170). d Light micrograph, similar to that shown in panel c, shows S1 and S2
segments at higher power (X425).
Eq 02/mg/min, respectively. Likewise, DEAE treat-
ment resulted in a marked decline (P < 0.001) in
state 3 respiration from 622 11 to 470 18 natom
Eq 02/mg'min. Once again, neutral dextran admin-
istration had no effect on state 3 respiration, aver-
aging 608 12 natom Eq 02/mg!rnin. Finally,
DEAE led to a significant (P < 0.001) fall in DNP-
uncoupled respiration from a control of 506 8 to
427 17 natom Eq 02/mglmin. DNP-uncoupled
respiration was not changed after in vivo neutral
dextran exposure and averaged 515 10 natom
Eq 02/mg/min.
Figure 3 illustrates ADP:0 and ACR ratios of
these three groups of rats. As shown, ACR declined
from 3.77 0.09 to 3.28 0.15 (P < 0.02); but
ADP:0 ratios were not statistically different, aver-
aging 1.72 0.09 and 1.49 0.09 nmoles ADP/
nmole Eq 02 in sham-control versus DEAE-treated
rats, respectively. The ACR and ADP:0 ratios were
not affected by neutral dextran treatment, averaging
3.73 0.1 and 1.75 0.09.
BUN values after 24 hours of low-dose DEAE
were identical to control values 16 3 mg/dl. Mor-
phologically, the kidneys exposed to low-dose
DEAE at 24 hours had no evidence of renal cell in-
jury.
Mitchondrial function after in vitro DEAE ex-
posure. The in vitro effects of DEAE (100 tgIm1) on
renal mitochondrial respiratory parameters are de-
tailed in Table 1 and are compared with those in
response to neutral dextran (100 sg!m1) and sham-
control preparations. DEAE resulted in a stimula-
tion in state 4 respiration (P <0.001) and significant
reductions in both state 3 and DNP respiration (P <
0.05, P <0.01) compared with neutral dextran and
sham controls. Because of the concomitant rise in
state 4 and decline in state 3, DEAE dramatically
reduced (P < 0.001) ACR from control and neutral
I £r
at
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Fig. 2. Effects of low dose DEAE, neutral dextran, and sham
treatment on renal mitochondrial respiration when succinate
was used as substrate. Mitochondria were isolated 24 hours after
injection. P values indicate significant differences of DEAE
group relative to neutral dextran and sham-control groups. N = 6
for all groups.
dextran values. ADP:0 ratios were not affected by
DEAE. Of note, the absolute values of control
mitochondrial parameters obtained after in vitro ex-
posure differ slightly from the control measure-
ments observed after in vivo exposure. As detailed
in the Methods section, only mitochondrial prepara-
tions with ACR's greater than 3.5 were used for the
experiments after in vitro exposure in order to max-
imize the uniformity of the test system for this
phase of the work. Consequently, these mitochon-
drial preparations display less uncoupling, tighter
respiratory control, and higher ACR's than those
from the in vivo treatment study, which of necessity
included all preparations and thereby explains, at
least in part, the differences in mitochondrial func-
tion values.
Discussion
Although the whole-organ physiologic events of
nephrotoxin-induced acute renal failure have been
extensively studied [10], little is known of the mo-
Fig. 3. Effects of low-dose DEAE, neutral dextran, and sham
treatment on renal cortical mitochondrial acceptor control ratios
(ACR) and ADP:O ratios. (See Methods to define terminology
for ratios.) Mitochondria were isolated 24 hours after injection. P
values indicate significant differences of DEAE group relative to
neutral dextran and sham control groups. N = 6 for all groups.
lecular and biochemical determinants of nephrotox-
in-related renal cell injury. In this regard, a large
number of nephrotoxins are cationic in nature. The
aminoglycoside antibiotics, which are organic poly-
cations, and the heavy metals, which are inorganic
cations, are preeminent examples. Recent evidence
has shown a correlation between the isoelectric
point (p1) of a myeloma light chain and its experi-
mental nephrotoxicity [1]. Specifically, the higher
the p1 of the light chain, that is, the more cationic
the light chain, the greater its nephrotoxic potential.
Furthermore, the cationic nature of myoglobin (p1,
6.8) has been suggested to be an important determi-
nant of its nephrotoxicity [2].
A variety of studies have also recently implicated
nephrotoxin-induced renal mitochondrial injury as
an important biochemical pathogenetic pathway for
renal cell injury. Mercurials [11], platinum coordi-
nation complexes [12], phenacetin [13], cephalori-
dine [14], and gentamicin [3] all inhibit mitochon-
Table 1. Effects of DEAE and neutral dextran on respiratory parameters of renal cortical mitochondria in vitro a
Groups(N = 6)
natom eq
Respiratory rates
uivalents O2Img protein/mm
ACR ADP/0State 4 State 3 DNP
Control 88 5 395 14 288 6 4.56 0.29 1.67 0.05
Neutral dextran (100 mg/ml 96 8 402 10 280 10 4.40 0.30 1.70 0.07
DEAEdextran(1OOg/ml) 211 10 339 4 227 17 1.63 0.10 1.65 0.02b <0.01 <0.05 <0.05 <0.001 NS
a Data are the means SEM.
b The P value is for DEAE relative to neutral dextran and control.
NS
600 /
.
CSSmINO) ...
500— C Neutral dextran
I c DEAE dextran
P (0.001
300
100
0 Li
State 3State 4 DNP
_1_.r? Csham(N6)
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drial oxidative phosphorylation in vitro and, for
mercury, cisplatinum, cephaloridine, and genta-
micin, at least, in vivo as well [3, 11, 12, 14]. The
nature of these nephrotoxin-mitochondrial interac-
tions has, up to now, been best detailed for genta-
micin, in particular, and the aminoglycosides, in
general. Gentamicin inhibits renal cortical mito-
chondrial oxidative phosphorylation in vitro by
both uncoupling electron transport from phosphor-
ylation, as evidenced by a stimulatory effect on
state 4 respiration, and blocking mitochondrial elec-
tron transport, as evidenced by inhibition of state 3
and DNP-uncoupled respiration [22]. These effects
on mitochondrial respiration are due to a specific
action of gentamicin to increase mitochondrial
monovalent cation permeability at a magnesium-
sensitive site [22, 23]. Of significant interest, neo-
mycin, kanamycin, and streptomycin have effects
qualitatively similar to those of gentarnicin on state
4, state 3, and DNP-uncoupled mitochondrial res-
piration; and the potency of the aminoglycosides
in producing these effects correlates strikingly with
the number of ionizable amino groups, and, there-
fore, the cationic charge of the aminoglucoside
molecule [4]. A similar correlation between cationic
charge and the toxic potency of various aminogly-
cosides have also been observed for ototoxicity [15],
neuromuscular paralysis [16], nephrotoxicity [17],
and whole animal toxicity [18]. Cationic charge,
therefore, appears to be an important determinant
of aminoglycoside toxicity at both the subcellular
and whole organ level.
The present experiments were undertaken to fur-
ther assess the role of cationic charge in nephrotox-
icity and renal mitochondrial injury. The cationic
nature of the aminoglycosides is due to amino-con-
taining side chains of amino sugars in glycosidic
linkage [4]. Similarly, DEAE dextran consists of
amino-containing side chains (diethylaminoethyl)
attached to glucose residues in glycosidic linkage.
The results of these experiments clearly show that
high-dose DEAE dextran administration to rats re-
sulted in marked renal dysfunction, with BUN ele-
vations exceeding 100 mgldl at 72 hours, and severe
acute tubular necrosis, morphologically, as early as
36 hours after injection. That the cationic nature of
DEAE imparted nephrotoxic potential to the mole-
cule is suggested by the findings that administration
of equivalent doses of neutral dextran, a molecule
identical to DEAE dextran but devoid of amino-
containing side chains, induced no rise in BUN or
morphologic evidence of renal cell injury.
That the renal morphologic and functional altera-
tions observed with DEAE administration were
most likely due to a direct toxic insult to the kidney
rather than a prolonged ischemic event is suggested
by several findings. Severe morphologic changes
occurred in the kidney as early as 36 hours after
DEAE administration, but animals survived for
more than 72 hours, suggesting that severe cardio-
vascular collapse did not occur in the animals. No
evidence of ischemic injury was found in other ex-
amined organs, including liver and spleen. Further-
more, only S1 and S2 segments, and not S3 seg-
ments, of the proximal tubule were selectively in-jured in this model, a pattern different from
ischemic models in which S3 segments appear to be
much more susceptible to injury than S1 and S2 seg-
ments are [9].
Low-dose DEAE administration did not induce
any morphologic signs of major renal cell injury 24
hours after injection. At this time, however, renal
cortical mitochondrial function was significantly al-
tered. State 4, state 3, and DNP-uncoupled respira-
tion were all inhibited. That these alterations may
be due to a direct, rather than an indirect, effect of
DEAE is suggested by the fact that in vitro ex-
posure of isolated renal mitochondria with 100 g/
ml of DEAE also altered mitochondrial respiratory
parameters. These effects were not seen with equiv-
alent doses of neutral dextran.
The intracellular concentrations of this com-
pound achieved in vivo is not known. DEAE may
well be concentrated within the renal tubular cell by
active or passive modalities. Because it is chem-
ically similar to the aminoglycosides, DEAE may
be actively transported by the same systems re-
sponsible for aminoglycoside transport [19, 20]. Ad-
ditionally, the highly cationic structure of DEAE in
all likelihood results in a charge interaction, like
gentamicin, with the anionic membrane com-
ponents of the microvilli of the proximal tubule [21].
Subsequent endocytosis of these membrane struc-
tures may result in a high intracellular concentra-
tion of DEAE.
The mechanism by which DEAE may inhibit re-
nal mitochondrial function is suggested by the pat-
tern of changes in mitochondrial respiratory pro-
files. The decreases in both state 3, ADP-depen-
dent, and DNP-uncoupled respiration is consistent
with a DEAE-induced block, or blocks, of electron
transport along the cytochrome respiratory chain.
The stimulation of state 4 respiration observed in
vitro also suggests an uncoupling action of DEAE.
This effect, however, was not seen after in vivo ex-
posure. This discrepancy in state 4 effects after in
vitro and in vivo exposure may be due to an inabili-
ty to precisely duplicate the in vivo situation in vitro
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or to cumulative mitochondrial injury arising from
prolonged exposure both to the toxin and the envi-
ronment of an injured cell. Indeed, the present data
cannot define whether these observed mitochon-
drial derangements occurring after in vivo exposure
are due to primary direct effects of DEAE or due to
secondary indirect effects arising from DEAE-in-
duced alterations in other cellular processes. For
example, in addition to mitochondrial membrane al-
terations, DEAE may have detrimental effects on
other cellular membrane systems as well. The
plasma membranes of renal tubular cells are un-
doubtedly the initial sites of DEAE membrane in-
teraction. Alterations in the structure and function
of this membrane system may be as important
pathogenetically to irreversible epithelial cell injury
as are diminished cellular energy transformation
processes arising from mitochondrial dysfunction.
In all likelihood, no single membrane-toxin inter-
action is sufficient, rather each is necessary and in-
terrelated, in the pathogenesis of DEAE-induced
renal cell necrosis. In this regard, a component of
mitochondrial dysfunction may arise from altera-
tions in the intracellular environment due to
changes in outer membrane permeability. Similarly,
declines in cellular energy transformation processes
arising from mitochondria alterations may lead to
diminished capability for repair of plasma mem-
branes that are altered from direct toxin inter-
actions.
Conclusion. These studies demonstrate that addi-
tion of cationic diethylaminoethyl substitution
groups to an otherwise nontoxic neutral dextran
molecule imparts both nepthrotoxic and mitochon-
drial toxic potential to the synthesized compound.
Furthermore, these studies provide further evi-
dence that renal mitochondrial injury is involved in
the early pathogenesis of nephrotoxic acute renal
failure, and cationic charge can be an important mo-
lecular determinant of a compound's mitochondrial
and renal toxicity.
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